Topic: [NOBN] Nobel Biocare
Outlook – Most markets have stabilized, with certain markets returning to growth in 2010. However, the challenging economic environment is still exerting an adverse effect on patient flow and case acceptance, in particular for larger and more complex treatments.
Based on current momentum, we believe that the dental implant market is likely to record modest, low single-digit growth in 2010 and then show further improvement in 2011. Nobel Biocare continues to focus on strategy execution and making the necessary investments that will allow the company to return to at least market growth within the next six to nine months, inasmuch as we can now increasingly build on a strengthened organization and a broadened product portfolio.
